Acute nitric oxide synthase inhibition and endothelin-1-dependent arterial pressure elevation

Frontiers in Pharmacology

Volumn 5 APR, Issue , 2014, Pages

  Rapoport, Robert M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acute; Arterial blood pressure; Endothelin converting enzyme inhibitor; Endothelin receptor antagonist; Endothelin 1; Nitric oxide synthase inhibitor

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; LIDOCAINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHORAMIDON; VASOPRESSIN ANTAGONIST;

ANTIHYPERTENSIVE ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; DRUG PROTEIN BINDING; ENZYME INHIBITION; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; REVIEW; VASCULAR RESISTANCE;

EID: 84901054938     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00057     Document Type: Review

References (39)

1. Ahlborg, G., and Lundberg, J. M. (1997). Nitric oxide-endothelin-1 interaction in humans. J. Appl. Physiol. 82, 1593-1600.
2. Arrigoni, F., Ahmetaj, B., and Leiper, J. (2010). The biology and therapeutic potential of theDDAH/ADMA pathway. Curr. Pharm. Des. 16, 4089-4102. doi: 10.2174/138161210794519246
3. Banting, J. D., Friberg, P., and Adams, M. A. (1996). Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J. Hypertens. 14, 975-981. doi: 10.1097/00004872-199608000-00007
4. Baranyi, L., Campbell, W., Ohshima, K., Fujimoto, S., Boros, M., Kaszaki, J., et al. (1998). Antisense homology box-derived peptides represent a new class of endothelin receptor inhibitors. Peptides 19, 211-223. doi: 10.1016/S0196-9781(97)00370-7
5. Baranyi, L., Campbell, W., Ohshima, K., Fujimoto, S., Boros, M., and Okada, H. (1995). The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat. Med. 1, 894-901. doi: 10.1038/nm0995-894
6. Beck, C., Schwarte, L. A., Schindler, A. W., Scheeren, T. W., and Picker, O. (2007). Endogenous nitric oxide reduces the efficacy of the endothelin system to maintain blood pressure during high epidural anaesthesia in conscious dogs. Eur. J. Anaesthesiol. 24, 689-696. doi: 10.1017/S0265021507000142
7. Bourque, S. L., Davidge, S. T., and Adams, M. A. (2011). The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives. Am. J. Physiol. 300, R1288-R1295. doi: 10.1152/ajpregu.00397.2010
8. Bourque, S. L., Whittingham, H. A., Brien, S. E., Davidge, S. T., and Adams, M. A. (2012). Role of endothelin-1 in the hyper-responsiveness to nitrovasodilators following acute NOS inhibition. Br. J. Pharmacol. 165, 1992-1999. doi: 10.1111/j.1476-5381.2011.01696.x
9. Brochu, I., Houde, M., Desbiens, L., Simard, E., Gobeil, F., Semaan, W., et al. (2013). High salt induced hyerptension in B2 knockout mice is corrected by the ETA antagonist, A127722. Br. J. Pharmacol. 170, 266-277. doi: 10.1111/bph.12259
10. Czóbel, M., Kaszaki, J., Molnár, G., Nagy, S., and Boros, M. (2009). Nonspecific inhibition of nitric oxide synthesis evokes endothelin-dependent increases in myocardial contractility. Nitric Oxide 21, 201-209. doi: 10.1016/j.niox.2009.08.003
11. de Beer, V. J., Taverne, Y. J., Kuster, D. W., Najafi, A., Duncker, D. J., and Merkus, D. (2011). Prostanoids suppress the coronary vasoconstrictor influence of endothelin after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 301, H1080-H1089. doi: 10.1152/ajpheart.01307.2010
12. de Nucci, G., Thomas, R., D'Orleans-Juste, P., Antunes, E., Walder, C., Warner, T. D., et al. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A. 85, 9797-9800. doi: 10.1073/pnas.85.24.9797
13. Filep, J. G. (1997). Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade. Hypertension 30, 22-28. doi: 10.1161/01.HYP.30.1.22
14. Fink, J., Fan, N. Y., Rosenfeld, L., and Stier, C. T. Jr. (1998). Contribution of endothelin to the acute pressor response of L-NAME in stroke-prone spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 31, 618-622. doi: 10.1097/00005344-199804000-00022
15. Gardiner, S. M., Kemp, P. A., March, J. E., and Bennett, T. (1996). Effects of the non-peptide, non-selective endothelin antagonist, bosentan, on regional haemodynamic responses to NG-monomethyl-L-arginine in conscious rats. Br. J. Pharmacol. 118, 352-354. doi: 10.1111/j.1476-5381.1996.tb15409.x
16. Gellai, M., De Wolf, R., Fletcher, T., and Nambi, P. (1997). Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide. Pharmacology 55, 299-308. doi: 10.1159/000139542
17. Gomez-Alamillo, C., Juncos, L. A., Cases, A., Haas, J. A., and Romero, J. C. (2003). Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds. Hypertension 42, 831-836. doi: 10.1161/01.HYP.0000088854.04562.DA
18. Gratton, J. P., Cournoyer, G., Löffler, B. M., Sirois, P., and D'Orléans-Juste, P. (1997). ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension 30, 1204-1209. doi: 10.1161/01.HYP.30.5.1204
19. Hashimoto, N., Kuro, T., Taira, S., and Matsumura, Y. (1998). Different contributions of the endothelin ET(A) receptor to hypertension induced by acute or chronic inhibition of nitric oxide synthesis. J. Pharm. Pharmacol. 50, 1051-1058. doi: 10.1111/j.2042-7158.1998.tb06921.x
20. Hocher, B., Schwarz, A., Slowinski, T., Bachmann, S., Pfeilschifter, J., Neumayer, H. H., et al. (2004). In vivo interaction of nitric oxide and endothelin. J. Hypertens. 22, 111-119. doi: 10.1097/00004872-200401000-00020
21. Hubloue, I., Biarent, D., Abdel Kafi, S., Bejjani, G., Kerbaul, F., Naeije, R., et al. (2003). Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction. Eur. Respir. J. 21, 19-24. doi: 10.1183/09031936.03.00025403a
22. Kramp, R., Fourmanoir, P., and Caron, N. (2001). Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat. Am. J. Physiol. 281, F1132-F1140.
23. Lavallée, M., Takamura, M., Parent, R., and Thorin, E. (2001). Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail. Rev. 6, 265-276. doi: 10.1023/A:1011448007222
24. Lerman, A., Sandok, E. K., Hildbrand, F. L. Jr., and Burmett, J. C. Jr. (1992). Inhibition of endothelium-derived relaxing factor enhances endothelium-mediated vasoconstriction. Circulation 85, 1084-1898. doi: 10.1161/01.CIR.85.5.1894
25. Merkus, D., Sorop, O., Houweling, B., Boomsma, F., van den Meiracker, A. H., and Duncker, D. J. (2006). NO and prostanoids blunt endothelin-mediated coronary vasoconstrictor influence in exercising swine. Am. J. Physiol. 291, H2075-H2081. doi: 10.1152/ajpheart.01109.2005
26. Ming, Z., Parent, R., Thorin, E., and Lavallée, M. (1998). Endothelin-dependent tone limits acetylcholine-induced dilation of resistance coronary vessels after blockade of NO formation in conscious dogs. Hypertension 32, 844-848. doi: 10.1161/01.HYP.32.5.844
27. Montanari, A., Biggi, A., Carra, N., Fasoli, E., Calzolari, M., Corsini, F., et al. (2000). Endothelin-A blockade attenuates systemic and renal hemodynamic effects of L-NAME in humans. Hypertension 35, 518-523. doi: 10.1161/01.HYP.35.1.518
28. Nafrialdi, N., Jover, B., and Mimran, A. (1994). Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration. J. Cardiovasc. Pharmacol. 23, 765-771. doi: 10.1097/00005344-199405000-00011
29. Pollock, D. M., and Opgenorth, T. J. (1991). Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1. Am. J. Physiol. 261, R257-R263.
30. Qiu, C., Engels, K., and Baylis, C. (1995). Endothelin modulates the pressor actions of acute systemic nitric oxide blockade. J. Am. Soc. Nephrol. 6, 1476-1481.
31. Rapoport, R. M., and Zuccarello, M. (2012). Endothelin(A)-endothelin(B) receptor cross talk in endothelin-1-induced contraction of smooth muscle. J. Cardiovasc. Pharmacol. 60, 483-494. doi: 10.1097/FJC.0b013e31826f32c1
32. Richard, V., Hogie, M., Clozel, M., Löffler, B. M., and Thuillez, C. (1995). In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 91, 771-775. doi: 10.1161/01.CIR.91.3.771
33. Schmidt, A., Bayerle-Eder, M., Pleiner, H., Zeisner, C., Wolzt, M., Mayer, G., et al. (2001). The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men. Nitric Oxide 5, 370-376. doi: 10.1006/niox.2001.0357
34. Tamás, P., Bódis, J., Sulyok, E., Kovács, G. L., Hantosi, E., Molnár, G., et al. (2013). L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies. Scand. J. Clin. Lab. Invest. 73, 436-443. doi: 10.3109/00365513.2013.803230
35. Thompson, A., Valeri, C. R., and Lieberthal, W. (1995). Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am. J. Physiol. 269, H743-H748.
36. Thorin, E., Parent, R., Ming, Z., and Lavallée, M. (1999). Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans. Am. J. Physiol. 277, H524-H532.
37. Tresham, J. J., Cooper, E. J., Bednarik, J. A., Dusting, G. J., and May, C. N. (1994). Prolonged regional vasoconstriction produced by NG-nitro-L-arginine in conscious sheep. J. Cardiovasc. Pharmacol. 24, 144-150. doi: 10.1097/00005344-199407000-00022
38. Worthmann, H., Martens-Lobenhoffer, J., Joumaah, M., Li, N., Lichtinghagen, R., Hecker, H., et al. (2013). Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Stroke 44, 2128-2133. doi: 10.1161/STROKEAHA.113.001145
39. Xu, H., Fink, G. D., and Galligan, J. J. (2001). Endothelin-1-induced elevation in blood pressure is independent of increases in sympathetic nerve activity in normotensive rats. J. Cardiovasc. Pharmacol. 38, 784-795. doi: 10.1097/00005344-200111000-00015